Related Experiment Video
Updated: Sep 30, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Targeted therapies for cancer
1Department of Medicine, Department of Surgery, the University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1262A, Oklahoma City, OK, 73104, USA.
Abstract:
Targeted therapy is the key for improving overall survival while decreasing the undesirable adverse effects of cancer treatment. Patients who received matched targeted therapies showed dramatically improved overall survival (OS) and progression-free survival (PFS) compared to those without matched therapies. However, each patient responds to targeted therapy differently due to their unique genomic profile. The discrepancy of treatment response between clinical trials and real-world clinical practice highlights an unmet need to develop tailored therapies for individual patients. The development of cutting-edge technologies, such as next-generation sequencing, has enabled us to identify more actionable targets. In this special issue of BMC Medicine, a collection of highly translational and clinical oncology papers presented a series of studies on targeted therapies for a variety of cancer types, aiming to bridge the gap between genomic testing and precision medicine and spark innovations on improving the efficacy of targeted therapies.
Insights
Matched targeted therapies significantly improve patient survival and reduce side effects. Personalized cancer treatment, guided by genomic profiling, is crucial for optimizing outcomes in real-world clinical practice.
Area of Science:
- Oncology
- Genomics
- Precision Medicine
Background:
- Targeted therapy improves overall survival (OS) and progression-free survival (PFS) in cancer patients.
- Individual genomic profiles influence patient response to targeted therapies, creating a gap between clinical trials and real-world efficacy.
- Next-generation sequencing technologies facilitate the identification of actionable targets for tailored cancer treatments.
Discussion:
- Bridging the gap between genomic testing and clinical application is essential for advancing precision medicine.
- Translational research is key to translating genomic discoveries into effective patient treatments.
- Addressing the heterogeneity of treatment responses requires personalized therapeutic strategies.
Key Insights:
- Matched targeted therapies demonstrate superior outcomes compared to unmatched therapies.
- Genomic profiling is fundamental for predicting and optimizing individual patient responses to cancer treatments.
- Innovations in targeted therapy aim to enhance efficacy and minimize adverse effects.
Outlook:
- Future research should focus on integrating genomic data into routine clinical practice for personalized cancer care.
- Continued development of targeted therapies holds promise for improving long-term cancer patient survival.
- Collaboration between researchers and clinicians is vital for advancing precision oncology.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer